{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T05:59:57Z","timestamp":1777269597040,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.metabol.2012.08.010","type":"journal-article","created":{"date-parts":[[2012,9,17]],"date-time":"2012-09-17T16:30:38Z","timestamp":1347899438000},"page":"341-346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["iNOS inhibitor, L-NIL, reverses burn-induced glycogen synthase kinase-3\u03b2 activation in skeletal muscle of rats"],"prefix":"10.1016","volume":"62","author":[{"given":"Masao","family":"Kaneki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"Shinozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Fukaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayu","family":"Habiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyungho","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Yasuhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A. Jeevendra","family":"Martyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2012.08.010_bb0005","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.00562.2007","article-title":"Post burn trauma insulin resistance and fat metabolism","volume":"294","author":"Cree","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2012.08.010_bb0010","doi-asserted-by":"crossref","first-page":"E585","DOI":"10.1152\/ajpendo.00321.2004","article-title":"Burn injury impairs insulin-stimulated Akt\/PKB activation in skeletal muscle","volume":"288","author":"Sugita","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2012.08.010_bb0015","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/0148607199023003160","article-title":"The metabolic basis of the increase of the increase in energy expenditure in severely burned patients","volume":"23","author":"Yu","year":"1999","journal-title":"JPEN"},{"key":"10.1016\/j.metabol.2012.08.010_bb0020","first-page":"403","article-title":"Critical illness myopathy: what is happening?","volume":"9","author":"Friedrich","year":"2006","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.metabol.2012.08.010_bb0025","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1378\/chest.06-2065","article-title":"ICU-acquired weakness","volume":"131","author":"Schweickert","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.metabol.2012.08.010_bb0030","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1432-1033.1980.tb06060.x","article-title":"Glycogen synthase from rabbit skeletal muscle. Amino acid sequence at the sites phosphorylated by glycogen synthase kinase-3, and extension of the N-terminal sequence containing the site phosphorylated by phosphorylase kinase","volume":"107","author":"Rylatt","year":"1980","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.metabol.2012.08.010_bb0035","doi-asserted-by":"crossref","first-page":"17934","DOI":"10.1074\/jbc.274.25.17934","article-title":"The role of glycogen synthase kinase 3beta in insulin-stimulated glucose metabolism","volume":"274","author":"Summers","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2012.08.010_bb0040","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ncb1101-1009","article-title":"Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K\/Akt\/mTOR and PI(3)K\/Akt\/GSK3 pathways","volume":"3","author":"Rommel","year":"2001","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.metabol.2012.08.010_bb0045","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1210\/en.2004-0869","article-title":"Protein breakdown in muscle from burned rats is blocked by insulin-like growth factor I and glycogen synthase kinase-3beta inhibitors","volume":"146","author":"Fang","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2012.08.010_bb0050","doi-asserted-by":"crossref","first-page":"R1545","DOI":"10.1152\/ajpregu.00244.2007","article-title":"GSK-3beta activity is increased in skeletal muscle after burn injury in rats","volume":"293","author":"Fang","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.metabol.2012.08.010_bb0055","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1172\/JCI11559","article-title":"Prevention of fat-induced insulin resistance by salicylate","volume":"108","author":"Kim","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2012.08.010_bb0060","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/ALN.0b013e3181799d45","article-title":"Obesity-induced insulin resistance and hyperglycemia: etiologic factors and molecular mechanisms","volume":"109","author":"Martyn","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1016\/j.metabol.2012.08.010_bb0065","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/nm1001-1138","article-title":"Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle","volume":"7","author":"Perreault","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2012.08.010_bb0070","doi-asserted-by":"crossref","first-page":"14203","DOI":"10.1074\/jbc.M411226200","article-title":"Inducible nitric-oxide synthase and NO donor induce insulin receptor substrate-1 degradation in skeletal muscle cells","volume":"280","author":"Sugita","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2012.08.010_bb0075","doi-asserted-by":"crossref","first-page":"E476","DOI":"10.1152\/ajpendo.00422.2005","article-title":"Targeted disruption of iNOS prevents LPS-induced S-nitrosation of IRbeta\/IRS-1 and Akt and insulin resistance in muscle of mice","volume":"291","author":"Carvalho-Filho","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.metabol.2012.08.010_bb0080","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.metabol.2011.06.001","article-title":"Inducible nitric oxide synthase deficiency ameliorates skeletal muscle insulin resistance but does not alter unexpected lower blood glucose levels after burn injury in C57BL\/6 mice","volume":"61","author":"Sugita","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2012.08.010_bb0085","doi-asserted-by":"crossref","first-page":"7511","DOI":"10.1074\/jbc.M411871200","article-title":"S-nitrosylation-dependent inactivation of Akt\/protein kinase B in insulin resistance","volume":"280","author":"Yasukawa","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2012.08.010_bb0090","doi-asserted-by":"crossref","first-page":"15160","DOI":"10.1074\/jbc.271.25.15160","article-title":"Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins","volume":"271","author":"Song","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2012.08.010_bb0095","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/0003-2697(68)90127-9","article-title":"A rapid filter paper assay for UDPglucose-glycogen glucosyltransferase, including an improved biosynthesis of UDP-14C-glucose","volume":"25","author":"Thomas","year":"1968","journal-title":"Anal Biochem"},{"key":"10.1016\/j.metabol.2012.08.010_bb0100","doi-asserted-by":"crossref","first-page":"34959","DOI":"10.1074\/jbc.M110.187666","article-title":"Liver-specific inducible nitric-oxide synthase expression is sufficient to cause hepatic insulin resistance and mild hyperglycemia in mice","volume":"286","author":"Shinozaki","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2012.08.010_bb0105","doi-asserted-by":"crossref","first-page":"9509","DOI":"10.1074\/jbc.M411648200","article-title":"Constitutive activation of GSK3 down-regulates glycogen synthase abundance and glycogen deposition in rat skeletal muscle cells","volume":"280","author":"MacAulay","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2012.08.010_bb0110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1254\/jphs.11093FP","article-title":"Lack of inducible nitric oxide synthase prevents lipid-induced skeletal muscle insulin resistance without attenuating cytokine level","volume":"117","author":"Cha","year":"2011","journal-title":"J Pharmacol Sci"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049512003149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049512003149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T03:58:43Z","timestamp":1758427123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049512003149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0026049512003149"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2012.08.010","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"iNOS inhibitor, L-NIL, reverses burn-induced glycogen synthase kinase-3\u03b2 activation in skeletal muscle of rats","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2012.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}